MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q4
hinzugefügt 06.05.2026
Trinity Biotech plc DSO 2011-2026 | TRIB
DSO Jährlich Trinity Biotech plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 87.2 | - | - | - | 65.5 | 113 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 113 | 65.5 | 88.5 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
94.7 | $ 1.29 | -20.86 % | $ 1.72 M |  USA |
 |
Agilent Technologies
A
|
63.8 | $ 111.67 | -1.39 % | $ 33.9 B | USA |
 |
Castle Biosciences
CSTL
|
50.2 | $ 19.22 | 1.8 % | $ 557 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 15.84 | -2.16 % | $ 479 M | USA |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 141.26 | -1.38 % | $ 22.5 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 19.81 | -3.34 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 93.52 | -3.26 % | $ 6.31 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 417.74 | -0.34 % | $ 12.1 B | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 039.9 | -0.19 % | $ 21.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M |  China |
 |
Myriad Genetics
MYGN
|
52.3 | $ 3.61 | -0.41 % | $ 334 M | USA |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
77.7 | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 18.7 | -1.22 % | $ 419 M | USA |
 |
Natera
NTRA
|
81.5 | $ 188.14 | -4.45 % | $ 18.5 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 154.29 | -3.04 % | $ 7.65 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
46.1 | $ 94.56 | -4.16 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
63.8 | $ 6.45 | -3.95 % | $ 576 M | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 117.67 | 0.5 % | $ 9.71 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
1.04 | $ 5.7 | -2.06 % | $ 238 M | USA |
 |
Soleno Therapeutics
SLNO
|
27 | $ 52.99 | - | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
57.7 | $ 2.36 | -2.07 % | $ 5.42 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 251.95 | -0.81 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 439.75 | -1.87 % | $ 166 B | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 48.67 | -8.08 % | $ 2.91 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 8.22 | -2.49 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 187.17 | -0.41 % | $ 20.8 B | USA |
 |
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | USA |